financetom
Business
financetom
/
Business
/
NovaBay Pharma Signs Deal to Sell Avenova Assets to Acumen Health Unit for $9.5 Million; Shares Soar
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NovaBay Pharma Signs Deal to Sell Avenova Assets to Acumen Health Unit for $9.5 Million; Shares Soar
Sep 22, 2024 9:17 AM

08:55 AM EDT, 09/20/2024 (MT Newswires) -- NovaBay Pharmaceuticals ( NBY ) shares were up 77% premarket Friday after the company said it signed a deal to sell its Avenova brand and assets to an Acumen Health unit for $9.5 million in cash.

The transaction is expected to close in Q4, subject to approval by NovaBay shareholders and customary closing conditions.

Price: 0.8796, Change: +0.38, Percent Change: +77.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Camp4 Therapeutics Seeks to Raise Up to $100 Million in Private Placement; Shares Up Pre-Bell
Camp4 Therapeutics Seeks to Raise Up to $100 Million in Private Placement; Shares Up Pre-Bell
Sep 10, 2025
08:17 AM EDT, 09/10/2025 (MT Newswires) -- Camp4 Therapeutics ( CAMP ) said Wednesday that it has signed agreements with certain investors to raise as much as $100 million through a private placement. The clinical-stage company said the net proceeds from the placement will be used to fund the preclinical and clinical development of its program to treat Syngap1-related disorders,...
BioHarvest Sciences Says Successfully Produced Plant-Based Exosomes at Scale
BioHarvest Sciences Says Successfully Produced Plant-Based Exosomes at Scale
Sep 10, 2025
08:18 AM EDT, 09/10/2025 (MT Newswires) -- BioHarvest Sciences ( BHST ) said Wednesday it advanced its proprietary botanical synthesis platform by successfully producing plant-based exosomes at scale in its VINIA bioreactors. The production of exosomes adds a potential new revenue stream from products and contract development and manufacturing organizations, the company said. BioHarvest's exosomes contain viniferin and are designed...
Market Chatter: Toyota to Build Electric SUVs at Kentucky Plant
Market Chatter: Toyota to Build Electric SUVs at Kentucky Plant
Sep 10, 2025
08:19 AM EDT, 09/10/2025 (MT Newswires) -- Toyota Motor ( TM ) will begin manufacturing two battery-powered sport utility vehicles at its Kentucky plant while ending the production of a Lexus model at the facility, Reuters reported Wednesday, citing a person familiar with the matter. The EVs will be based on the RAV4 and Land Cruiser models, the source said....
Hovnanian Enterprises Unit Plans Private Placement of $900 Million of Senior Notes
Hovnanian Enterprises Unit Plans Private Placement of $900 Million of Senior Notes
Sep 10, 2025
08:18 AM EDT, 09/10/2025 (MT Newswires) -- Hovnanian Enterprises ( HOV ) said Wednesday that its K. Hovnanian Enterprises unit plans a private placement of $450 million of senior notes due 2031 and $450 million of senior notes due 2033. The company said K. Hovnanian ( HOV ) intends to use the net proceeds to fund the redemption of certain...
Copyright 2023-2026 - www.financetom.com All Rights Reserved